OCRA’s Advocate Leader Program is now open. Apply today.

Be a voice for the ovarian cancer community.

Update: The deadline to apply for our 2019 Advocate Leader program has now passed.

(August 28, 2018) Registration is now open for our 2019 Advocate Leader program. Apply today to join our diverse community of survivors, caregivers and activists from across the country using their voices to effect change for those touched by ovarian cancer.

As an Advocate Leader, you’ll learn how to educate federal and state policymakers about the disease, protect funding for life-saving research, and fight for expanded access to treatment and care. No legislative or advocacy experience is necessary to apply – just a willingness to learn and, most importantly, to speak up on behalf of the women and families who need it.

Your voice makes a difference. Join us to ensure your elected officials keep ovarian cancer a priority.

Apply Today

Advocacy in Action

This spring, OCRA Advocate Leaders successfully rallied for a significant increase in governmental ovarian cancer funding.

Their hard work resulted in a $2 million increase to the CDC’s Ovarian Cancer Control Initiative, $1.5 million increase to Johanna’s Law for ovarian cancer education and awareness, and nearly 10% increase in NIH funding!

 

Meet Sayla, OCRA Advocate Leader

Sayla, a survivor currently in treatment, became an Advocate Leader earlier this year. She has no prior advocacy experience, but is determined to use her experience to help other women.

OCRA: What would you say to someone who’s thinking about becoming an OCRA Advocate Leader?

S: There is so much to learn from OCRA. There are endless amounts of things I can do as an advocate that I haven’t even tapped into yet. I encourage everyone to get involved. Even if you can’t travel, or if you’re shy, or if you’re a private person who isn’t comfortable sharing your story, you can get involved in other ways. Email your representatives, become part of a phone tree. There are many tiers for getting involved. It’s not an all-or-nothing thing.

Read more >>